1.
Am J Gastroenterol
; 94(12): 3632-3, 1999 Dec.
Article
in English
| MEDLINE
| ID: mdl-10606333
ABSTRACT
We describe a case of prolonged cholestasis temporally associated with the use of itraconazole for onychomycosis. Peak bilirubin level of 32.0 mg/dl was documented approximately 2 months after discontinuation of the patient's itraconazole therapy, with symptoms of cholestasis persisting more than 1 month after the peak in bilirubin. Physicians should be aware of the potential for severe cholestasis associated with itraconazole usage.